- Home
- PHIO
PHIO
Phio Pharmaceuticals Corp.
as 04-04-2025 4:00pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $4.00 | AVG Volume (30 days): | 86.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.05 - $9.79 | Next Earning Date: | 05-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Phio Pharmaceuticals Corp. News
PHIO Breaking Stock News: Dive into PHIO Ticker-Specific Updates for Smart Investing
Newsfile
2 days ago
Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894
Newsfile
5 days ago
Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update
Newsfile
a month ago
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting
Newsfile
a month ago
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
Newsfile
a month ago
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Newsfile
a month ago
Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors
Newsfile
2 months ago
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Newsfile
2 months ago
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Compare PHIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHIO Phio Pharmaceuticals Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.